Top

12-08-2017 | Diagnosis | Case report | Article

A Case of Maturity Onset Diabetes of the Young (MODY3) in a Family with a Novel HNF1A Gene Mutation in Five Generations

Journal: Diabetes Therapy

Authors: A. K. Ovsyannikova, O. D. Rymar, D. E. Ivanoshchuk, Svetlana V. Mikhailova, E. V. Shakhtshneider, P. S. Orlov, E. S. Malakhina, M. I. Voevoda

Publisher: Springer Healthcare

Abstract

Diabetes mellitus with autosomal dominant inheritance, i.e., maturity-onset diabetes of the young (MODY), is a genetic form of diabetes mellitus. The MODY phenotype is associated with gene mutations leading to pancreatic β-cell dysfunction. Here, we present the clinical case of a 50-year-old proband with familial diabetes mellitus in five generations (proband, her mother, grandmother, great-grandfather, and son). This disease is most likely associated with the novel Ser6Arg mutation in the HNF1A gene, which was identified in four family members. The mutation was not detected in MODY patients (126 subjects), in patients with type 2 diabetes mellitus (188 subjects), and in a general population sample (564 subjects).

Lachanse CH. Practical aspects of monogenic diabetes: a clinical point of view. Can J Diabetes. 2016;40:368–75.CrossRef

Rubio-Cabezas O, Hattersley AT, Njolstad PR, et al. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2014;15(20):47–64.CrossRefPubMed

Fajans SS, Bell GI. MODY: history, genetics, pathophysiology, and clinical decision making. Diabetes Care. 2011;34(8):1878–84.CrossRefPubMedPubMedCentral

Stanik J, Dusatkova P, Cinek O, et al. De novo mutations of GCK, HNF1a and HNF 4a may be more frequent in MODY than previously assumed. Diabetologia. 2014;57:480–4.CrossRefPubMed

Voevoda MI, Ivanova AA, Shakhtshneider EV, et al. Molecular genetics of maturity-onset diabetes of the young. Ther Arch. 2016;88(4):117–24.

Pihoker C, Gilliam MK, Ellard S, et al. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1a, HNF4a, and glucokinase: results from the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab. 2013;98:4055–62.CrossRefPubMedPubMedCentral

Agarwal SK, Khatri S, Prakash N, et al. Maturity onset diabetes of young. JIACM. 2002;3(3):271.

Thanabalasingham G, Pal A, Selwood MP, et al. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young. Diabetes Care. 2012;35:1206–2012.CrossRefPubMedPubMedCentral

McDonald TJ, Ellard S. Maturity onset diabetes of the young: identification and diagnosis. Ann Clin Biochem. 2013;50(Pt 5):403–15.CrossRefPubMed

10.

Bonnefond A, Philippe J, Durand E, et al. Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene. PLoS One. 2012;7(6):e37423. doi: 10.1371/journal.pone.0037423

11.

Delvecchio M, Ludovico O, Menzaghi C, et al. Low prevalence of HNF1A mutations after molecular screening of multiple MODY genes in 58 Italian families recruited in the pediatric or adult diabetes clinic from a single Italian hospital. Diabetes Care. 2014;37:258–60.CrossRef

12.

Thanabalasingham G, Owen KR. Diagnosis and management of maturity onset diabetes of the young (MODY). BMJ. 2011;343:d6044. doi: 10.1136/bmj.d6044 CrossRef

13.

Shields BM, Hicks S, Shepherd MH, et al. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia. 2010;53:2504–8.CrossRefPubMed

14.

Kuraeva TL, Sechko EA, Eremina IA, Ivanova ON, Proko’ev SA. MODY3 in the child with type 2 diabetes mellitus phenotype: case report. Diabetes mellitus. 2013;2(59):88–93.CrossRef

15.

Sambrook J, Russell DW. Purification of nucleic acids by extraction with phenol:chloroform. CSH Protoc. 2006;(1). doi: 10.1101/pdb.prot4455

16.

Mendel DB, Crabtree GR. HNF-1, a member of a novel class of dimerizing homeodomain proteins. J Biol Chem. 1991;266(2):677–80.PubMed

17.

Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–9.CrossRefPubMedPubMedCentral

18.

Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073–81.CrossRefPubMed

19.

Eide SA, Raeder H, Johansson S, et al. Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study). Diabet Med. 2008;25(7):775–81. https://doi.org/10.1111/j.1464-5491.2008.02459.x.CrossRefPubMed

20.

Pajak A, Szafraniec K, Kubinova R, et al. Binge drinking and blood pressure: cross-sectional results of the HAPIEE Study. PLoS One. 2013;8(6):e65856. https://doi.org/10.1371/journal.pone.0065856.CrossRefPubMedPubMedCentral

21.

Ovsyannikova AK, Rymar OD, Shakhtshneider EV, et al. ABCC8-related maturity-onset diabetes of the young (MODY 12). Diabetes Ther. 2016;7:591–600.CrossRefPubMedPubMedCentral

22.

Shields BM, Peters JL, Cooper C, et al. Is there an evidence base for the clinical features used to differentiate type 1 from type 2 diabetes? A systematic review of the literature. Diabetologia. 2014;57(11):439–40.

23.

Shields BM, McDonald TJ, Ellard S, et al. The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia. 2012;55:1265–72.CrossRefPubMedPubMedCentral

24.

Bellanné-Chantelot C, Carette C, Riveline J, et al. The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3. Diabetes. 2008;57:503–8.CrossRefPubMed

25.

Steele AM, Shields BM, Shepherd M, et al. Increased all-cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene. Diabet Med. 2010;27:157–61.CrossRefPubMed

26.

Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43(3):515–24.CrossRefPubMed

27.

Wobser H, Bonner C, Nolan JJ, et al. Downregulation of protein kinase B/Akt-1 mediates INS-1 insulinoma cell apoptosis induced by dominant-negative suppression of hepatocyte nuclear factor-1alpha function. Diabetologia. 2006;49:519–26.CrossRefPubMed

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform.

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »

Medicine Matters Diabetes

Abstract

Be confident that your patient care is up to date